he European Union Court of Justice has rejected an effort by the European Medicines Agency to release clinical trial data to third parties over the objections of a pair of drug makers.

The regulator had appealed two separate rulings by the General Court of the European Union, which last September temporarily blocked its attempt to release certain data for drugs sold by Merck and PTC Therapeutics. In rejecting the appeals, the Court of Justice determined the lower court did not err in concluding the companies could suffer financial harm if their data was released. As a result, the EMA must now wait until the cases are fully decided.

Unlock this article by subscribing to STAT Plus today. Try it FREE for 30 days and cancel anytime!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.

Privacy Policy